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The safety of bronchoscopy and speciﬁcally transbronchial biopsy has not been studied in patients with
bronchiolitis obliterans. We discuss two patients with bronchiolitis obliterans as a complication of graft
versus host disease following allogeneic stem cell transplant. Both underwent bronchoscopy and
transbronchial biopsy, which was complicated by pneumothoraces. Patients with bronchiolitis obliterans
have an increased risk of spontaneous air leak syndromes. Although no data exists regarding the safety of
transbronchial biopsies in patients with airﬂow obstruction in general, they appear to have increased
rates of pneumothoraces following transthoracic biopsies. It is important to consider the potentially
increased risk of pneumothoraces when deciding to pursue bronchoscopy and transbronchial biopsy in
patients with bronchiolitis obliterans.
 2009 Elsevier Ltd. All rights reserved.Pulmonary complications following hematopoietic stem cell
transplant (HSCT) are common and add signiﬁcantly to morbidity
and mortality. Both infectious and noninfectious complications
occur in 50–60% of HSCT recipients and nearly one third of patients
require intensive unit care.1,2 The most common noninfectious
pulmonary complications are idiopathic pneumonia syndrome,
bronchiolitis obliterans (BO), diffuse alveolar hemorrhage, and
cryptogenic organizing pneumonia.3,4 Bronchoscopy has become
the diagnostic modality of choice in HSCT patients presenting with
respiratory symptoms and/or pulmonary inﬁltrates, however the
utility and safety of the procedure in this patient population is
unclear. Bronchiolitis obliterans, in particular, has been associated
with spontaneous air leak syndromes which potentially may
increase the risk of complications after a bronchoscopy and trans-
bronchial biopsy. We describe two patients with a history of allo-
geneic stem cell transplant complicated by bronchiolitis obliterans,
who developed pneumothoraces after bronchoscopy and trans-
bronchial biopsy.1. Case one
A 51-year-old female with a history of anaplastic large cell
lymphoma, status-post allogeneic HSCT 2 years prior, was admitted
with a complaint of shortness of breath for ﬁve days. She had
associated wheezing, productive cough, and low grade fevers up to: þ1 614 293 4799.
od).
rved.99.9. Her past medical history included cutaneous and gastroin-
testinal graft versus host disease (GVHD) and ultimately bron-
chiolitis obliterans.
Her pulmonary function tests prior to her stem cell transplant
were normal with an FEV1/FVC of 72%. During admission, her
pulmonary function tests showed an FEV1/FVC of 44%, FEV1 of
1.29 L (52% predicted), and FVC of 2.63 L (88% predicted). Chest CT
with high resolution cuts revealed centrilobular nodular opacities
in the bilateral lower lobes. The patient underwent a bronchoscopy
with bronchoalveolar lavage and transbronchial biopsy which was
complicated by a pneumothorax (PTX) necessitating chest tube
placement.2. Case two
A 25-year-old man with a history of acute lymphoblastic
leukemia, status-post allogeneic HSCT four years prior was
admitted to the hospital for worsening dyspnea and hypoxemia. His
post transplant course had been complicated by graft versus host
disease, bronchiectasis with pseudomonas colonization, and
chronic sinusitis. Pulmonary function testing done prior to trans-
plant was normal with an FEV1/FVC ratio of 75%. One year after his
transplant, his pulmonary function testing showed an FEV1/FVC of
68%, FEV1 3.77 L (79% predicted), and FVC of 5.49 L (99% predicted).
Subsequent PFT’s have shown worsening airﬂow obstruction
consistent with bronchiolitis obliterans.
Upon admission to the hospital, the patient had a chest CT done
which revealed diffuse ground glass inﬁltrates. The patient
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transbronchial biopsy. This was complicated by a right sided
pneumothorax requiring multiple chest tubes and invasive venti-
lation. He continued to have a persistent air leak due to a bron-
chopleural ﬁstula which required VATS and mechanical
pleurodesis.
3. Discussion
We describe two patients with a history of allogeneic stem cell
transplant complicated by bronchiolitis obliterans (BO) who have
suffered from pneumothoraces following bronchoscopy and
transbronchial biopsy. Bronchiolitis obliterans is a well known
complication of allogeneic stem cell transplant, and is felt to be the
pulmonarymanifestation of chronic graft versus host disease. It has
been reported to occur in approximately 8-10% of patients
following allogeneic stem cell transplant.5 Themost recognized risk
factor for the development of BO in stem cell transplants is chronic
GVHD.5,6 Death caused by respiratory failure usually occurs within
three years in 65% of cases.7
Interestingly, several case reports have described patients with
BO who have suffered from spontaneous pneumothoraces, spon-
taneous pneumomediastinum and subcutaneous emphysema.5,8,9
The mechanism is unknown but is thought to occur from rupture of
subpleural blebs that form secondary to severe obstruction of the
terminal bronchioles leading to air trapping and development of
bullae.8 Franquet et al. retrospectively reviewed 292 allogeneic
stem cell transplant patients and found 158 with chronic GVHD.10
Fourteen of those patients developed BO (8.9%) of which nine
developed spontaneous air leak syndromes. Two of the nine
patients died as a result of their air leak syndromes. Spontaneous
mediastinal emphysema and bilateral pneumothorax, in particular,
are a rare yet ominous complication seen in BO. In one review, air
leak syndrome was diagnosed in ﬁve of 69 patients with chronic
GVHD who had undergone HSCT, with all ﬁve dying from this
complication.11
The safety and utility of bronchoscopy and transbronchial
biopsy in patients with BO is not speciﬁcally addressed in the
literature. However, there are many retrospective reviews evalu-
ating the safety and utility of bronchoscopies in stem cell transplant
patients in general. The diagnostic yield of a ﬁberoptic bronchos-
copy (FOB) in HSCT patients is anywhere between 11% and 53%.12–16
Peikert et al. performed a retrospective review of patients with
neutropenic fever and pulmonary inﬁltrates of which 29 of the 35
patients had undergone HSCT.17 Bronchoalveolar lavage was
deemed safe as only two out of the 29 patients requiredmechanical
ventilation and one patient required observation in the intensive
care unit post-procedure. Nine patients underwent a BAL and
a transbronchial biopsy (TBBX); however the biopsy added one
additional diagnosis and one change in management and caused
one episode of self-limited hemorrhage. Fifty-one percent of the
patients had a change in management based on the BAL results.
They concluded that BAL results in management changes but TBBX
adds little utility in this setting.
The utility of FOB and the impact on mortality in the stem cell
transplant patient has been questioned in several studies.8,9,14,18,19
White et al.14 reviewed 68 FOB of which 42 procedures consisted of
both BAL and TBBX on HSCT patients. A diagnosis was made in 31%
of cases and a change in therapy occurred in 24%, however patients
who had a diagnostic bronchoscopy or a bronchoscopy resulting in
change in therapy did not have any improvement in hospital or
6-month survival compared to those who had a nondiagnostic
bronchoscopy. More importantly, 10 complications (15%) occurred
involving nine patients including three pneumothoraces. TBBX only
provided one additional infectious diagnosis and did not result ina change in therapy. TBBX has not been proven to increase diag-
nostic yield in the HSCT population, but may potentially result in
increased complications, including pneumothoraces, bleeding and
intubation secondary to hypoxemia caused by bleeding.20,21
Why patients with BO seem to have an increased rate of pneu-
mothorax is unclear, but it may relate to the disease itself, the pre-
transplant radiation and chemotherapy, or simply reﬂect the
degree of airﬂow obstruction. Surprisingly, there are no studies in
the literature regarding the degree of airﬂow obstruction in pre-
dicting the risk of pneumothorax after TBBX, however, there are
studies pertaining to airﬂow obstruction and complications after
transthoracic biopsies. Earlier studies have shown conﬂicting
results, some demonstrating increased risk of PTX after trans-
thoracic needle biopsy in patients with obstructive lung
disease22,23 and some demonstrating no increased risk.24 Kazer-
ooni et al.25 retrospectively reviewed the charts of 190 patients
who were being evaluated for lung transplant of which eight
underwent a transthoracic needle aspirate (TTNA) for pulmonary
nodules. All eight had emphysemawith a mean FEV1 of 0.64 L (22%
predicted) and six developed PTX post-procedure (75%). Another
study showed that FEV1/FVC ratio was not a signiﬁcant predictor of
PTX in CT guided biopsies but was signiﬁcant in predicting chest
tube placement with FEV1% being the most signiﬁcant factor. FEV1%
<70% was associated with a 3-fold increased risk of chest tube
placement and six of the seven patients who needed surgical chest
tube placement for persistent air leak had an FEV% <50%.26
4. Conclusion
Pulmonary complications in stem cell transplant patients are
commonly seen and have led to increased need for diagnostic testing.
Bronchiolitis obliterans as amanifestation of graft versus host disease
can occur in allogeneic stem cell transplants and may lead to
spontaneous air leak syndromes. Bronchoscopy is a common diag-
nostic modality in this patient population; however the safety has
been questioned in the literature. Transbronchial biopsies, in partic-
ular, have not been shown to increase the diagnostic yield in this
population but may result in more frequent complications that are
potentially life threatening. We have presented two patients with
bronchiolitis obliterans who have had complications related to
pneumothoraces after bronchoscopy with transbronchial biopsies. It
is important to recognize air leak syndromes as a complication of BO
after BMT and consider the possibility of increased risk of PTX when
evaluating these patients for lung biopsies.
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